DrugsControl Media Services

News Detail

NPPA directs SII to continue manufacturing tetanus toxoid injections till Dec-31, 2024 (06-01-2024)

New Delhi, 6 Jan 2024: The National Pharmaceutical Pricing Authority (NPPA) has once again extended its mandate to Pune-based Serum Institute of India (SII) to continue manufacturing two of its scheduled formulations against tetanus for another one year, till December 31, 2024. S......
View Details

Source : Pharmabiz
NPPA Serum Institute of India SII tetanus Form IV DPCO 2013 API Biological E tetanus toxoid injections Dano Vaccines

Related News